{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:00:04Z","timestamp":1793660404469,"version":"4.5.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3653,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1111\/j.0022-202x.2005.23914.x","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T15:09:23Z","timestamp":1126796963000},"page":"1273-1278","source":"Crossref","is-referenced-by-count":40,"title":["Circulating Natural Killer Lymphocytes Are Potential Cytotoxic Effectors Against Autologous Malignant Cells in Sezary Syndrome Patients"],"prefix":"10.1016","volume":"125","author":[{"given":"Jean-David","family":"Bouaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Giustiniani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0010","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood.V91.11.4331","article-title":"Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma","volume":"91","author":"Bagot","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0015","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1046\/j.1523-1747.2000.00195.x","article-title":"Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population","volume":"115","author":"Bagot","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4+cutaneous T cell lymphoma cells express the p140\/Killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.1830220102","article-title":"Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells","volume":"22","author":"Baume","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1582-4934.2003.tb00240.x","article-title":"Human natural killer cell receptors: Insights into their molecular function and structure","volume":"7","author":"Biassoni","year":"2003","journal-title":"J Cell Mol Med"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/349329a0","article-title":"Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice","volume":"349","author":"Bix","year":"1991","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V57.3.526.526","article-title":"Surface antigens on malignant Sezary and T-CLL cells correspond to those of mature T cells","volume":"57","author":"Boumsell","year":"1981","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0045","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1073\/pnas.201238598","article-title":"Ectopic expression of retinoic acid early inducible-1-gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo","volume":"98","author":"Cerwenka","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35093109","article-title":"Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity","volume":"413","author":"Diefenbach","year":"2001","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1523-1747.2000.00995.x","article-title":"Cutaneous T cell lymphoma-reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a Fas-independent pathway for specific tumor cell lysis","volume":"115","author":"Echchakir","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: Mycosis fungoides, Sezary syndrome, and other variants","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0065","doi-asserted-by":"crossref","first-page":"10332","DOI":"10.1073\/pnas.88.22.10332","article-title":"Recognition of \u03b22-microglobulin-negative (\u03b22m-) T-cell blasts by natural killer cells from normal but not from \u03b22m-mice: Nonresponsiveness controlled by \u03b22m-bone marrow in chimeric mice","volume":"88","author":"Hoglund","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00404351","article-title":"Natural and concanavalin A-induced cytotoxic activity towards continuously growing B lymphocytes derived from patients with cutaneous T-cell lymphoma","volume":"279","author":"Jensen","year":"1986","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy","volume":"319","author":"Karre","year":"1986","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0609.2003.00143.x","article-title":"Treatment of patients with advanced mycosis fungoides and Sezary syndrome with alemtuzumab","volume":"71","author":"Kennedy","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJM198301133080214","article-title":"Decreased natural-killer-cell activity in cutaneous T-cell lymphomas","volume":"308","author":"Laroche","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0095","doi-asserted-by":"crossref","first-page":"16963","DOI":"10.1073\/pnas.012681099","article-title":"Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity","volume":"99","author":"Le Bouteiller","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.178.3.1121","article-title":"A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity","volume":"178","author":"Maiza","year":"1993","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archderm.1995.01690170076011","article-title":"High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma","volume":"131","author":"Marolleau","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-065X.1997.tb00943.x","article-title":"Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes","volume":"155","author":"Moretta","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0115","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood.V65.3.638.638","article-title":"Lysis of lymphoma cells by autologous and allogeneic natural killer cells","volume":"65","author":"Oshimi","year":"1985","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0120","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/10428199809058366","article-title":"Blocking of MHC class I antigens on leukemic B-cells enhances their conjugate formation with cytotoxic lymphocytes and their susceptibility to lysis","volume":"28","author":"Palucka","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0125","series-title":"Leucocyte Typing VII","first-page":"415","article-title":"The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles","author":"Parolini","year":"2002"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.184.2.505","article-title":"The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58\/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer","volume":"184","author":"Pende","year":"1996","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0135","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V96.3.1056","article-title":"Functional characterization of an IL-7-dependent CD4(+)CD8alphaalpha(+) Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma","volume":"96","author":"Poszepczynska","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0140","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: Relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Poszepczynska-Guigne","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0145","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/10428190310001598017","article-title":"Efficacy and tolerability of alemtuzumab (CAMPATH-1H) in the salvage treatment of B-cell chronic lymphocytic leukemia-change of regimen needed?","volume":"45","author":"Rieger","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0150","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in Sezary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/intimm\/dxh021","article-title":"Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers","volume":"16","author":"Tajima","year":"2004","journal-title":"Int Immunol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-1759(01)00361-1","article-title":"Measurement of NK activity by the microcytotoxicity assay (MCA): A new application for an old assay","volume":"253","author":"Wahlberg","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/MO:19:2S:S03","article-title":"A personal history of the CAMPATH-1H antibody","volume":"19s","author":"Waldmann","year":"2002","journal-title":"Med Oncol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.1251","article-title":"Killer cell immunoglobulin-like receptor expression delineates in situ sezary syndrome lymphocytes","volume":"199","author":"Wechsler","year":"2003","journal-title":"J Pathol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0190-9622(90)70054-L","article-title":"Sezary syndrome: Diagnosis, prognosis, and critical review of treatment options","volume":"22","author":"Wieselthier","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0180","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archderm.1990.01670310069009","article-title":"Depressed lymphokine activated killer cell activity in mycosis fungoides. A possible marker for aggressive disease","volume":"126","author":"Wood","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0185","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T Cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0190","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"Sezary syndrome patients demonstrate a defect in dendritic cell populations: Effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1067\/mjd.2001.116345","article-title":"Complete molecular remission during biologic response modifier therapy for Sezary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity","volume":"45","author":"Yoo","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2005.23914.x_bb0200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1523-1747.2002.01646.x","article-title":"Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: Basis for therapy of cutaneous T cell lymphoma","volume":"118","author":"Zaki","year":"2002","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15325896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T14:36:26Z","timestamp":1683210986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15325896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0022202X15325896"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2005.23914.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}